Groundbreaking Gene Therapy Study Gets The Go-Ahead By The FDA
Calimmune, a small biotechnology company, is giving people a low dose chemo agent (as conditioning) and then infusing them with stem cells that have been modified to inhibit the CCR5 receptor and to contain their own built-in HIV fusion inhibitor peptide, thereby blocking two sites that are essential for HIV infection. The study is …
Groundbreaking Gene Therapy Study Gets The Go-Ahead By The FDA Read More »